Results 51 to 60 of about 226,373 (256)

Impact of Radiation Therapy on Physical and Psychosocial Health of Adolescents and Young Adults: A Joint Report From the Children's Oncology Group AYA and Radiation Oncology Committees

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Rates of cancer among adolescents and young adults (AYA), age 15–39 years, are increasing. Consequently, radiation oncologists are treating more AYAs who have diagnoses spanning both pediatric and adult practices. Compared to pediatric and older adult patients, AYAs face a unique set of challenges.
Hesham Elhalawani, Rachel K. Peterson, Avani D. Rao, Laurie J. McKenzie, Ahmed Magdy Elmotayam, Leslie Chang, Michael Roth, Susan L. McGovern   +7 more
wiley   +1 more source

The radiobiology of radiosurgery and stereotactic radiotherapy

Medical Dosimetry, 1998
Radiation therapy has evolved into a complex amalgamation of treatment techniques that differ significantly according to the way the radiation is delivered to the patient and coincidentally according to the biologic effects that are observed with each technique.
Departments of Radiation Oncology and Neurosurgery, University of Florida College of Medicine, Gainesville, FL 32610, USA ( host institution ), Buatti, John M., Friedman, William A., Meeks, Sanford L., Bova, Francis J.   +4 more
openaire   +3 more sources

Intrapatient tumour heterogeneity and clonal evolution in an autopsy study of metastatic salivary gland cancer

Molecular Oncology, EarlyView.
Tumour heterogeneity and clonal evolution of metastatic salivary gland cancer were evaluated in two patients with adenoid carcinoma and one patient with myoepithelial carcinoma. Radiology‐guided autopsy enabled multi‐region sampling (total samples n = 149), followed by whole‐genome sequencing and phylogenetic reconstruction (17 tumour samples, 4–7 per ...
Gerben Lassche, Niels J. van Ruitenbeek, Charlotte Adang, Luke O'Gorman, Pui Yuen Lee, Willemijn M. Klein, Adriana C. H. van Engen‐van Grunsven, Jack A. Schalken, Sander Bervoets, Gerald W. Verhaegh, Carla M. L. van Herpen   +10 more
wiley   +1 more source

Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL study

Radiation Oncology, 2009
Background A phase III multi-centre randomised trial (ROSEL) has been initiated to establish the role of stereotactic radiotherapy in patients with operable stage IA lung cancer. Due to rapid changes in radiotherapy technology and evolving techniques for
van der Heide Uulke A, Widder Joachim, Lagerwaard Frank J, Cuijpers Johan P, Hurkmans Coen W, Schuring Danny, Senan Suresh   +6 more
doaj   +1 more source

Dosimetric verification of stereotactic body radiotherapy treatment plans for early stage non-small cell lung cancer using Monte Carlo simulation [PDF]

, 2017
This thesis is an evaluation of the dosimetric accuracy of the dose calculation algorithm used for planning of lung stereotactic body radiotherapy treatments.
Herwiningsih, Sri
core   +1 more source

A frameless method for stereotactic radiotherapy

The British Journal of Radiology, 1993
Abstract A frameless method for stereotactic multiple arc radiotherapy (SMART) is described. Three short gold wires are implanted in the scalp approximately 100 mm apart. These are localized in a computed tomographic or angiographic study along with the target.
D, Jones, D A, Christopherson, J T, Washington, M D, Hafermann, J W, Rieke, J J, Travaglini, S S, Vermeulen   +6 more
openaire   +2 more sources

Stereotactic radiotherapy for adrenal oligometastases

Reports of Practical Oncology and Radiotherapy, 2022
Approximately 50% of melanomas, 30-40% of lung and breast cancers and 10-20% of renal and gastrointestinal tumors metastasize to the adrenal gland. Metastatic adrenal involvement is diagnosed by computed tomography (CT ) with contrast medium, ultrasound (which does not explore the left adrenal gland well), magnetic resonance imaging (MRI) with contrast
Borghesi S., Casamassima F., Aristei C., Grandinetti A., Di Franco R.   +4 more
openaire   +4 more sources

Advanced Materials for Biologics Delivery to Brain Tumors

Advanced Materials, EarlyView.
Material innovation is central to unlocking the therapeutic potential of biologics against many central nervous system diseases, including brain cancer. By engineering carriers with controlled transport, targeting, and release properties, advanced materials can overcome the blood–brain barrier and tumor microenvironment, improving the delivery of ...
Yuran Feng, Yuxue Cao, Maria Kavallaris, Taskeen Janjua, Amirali Popat   +4 more
wiley   +1 more source

Stereotactic radiotherapy is a useful treatment option for patients with medullary thyroid cancer

BMC Endocrine Disorders, 2021
The role of radiotherapy in advanced medullary thyroid carcinoma (MTC) is confined to patients in whom surgical treatment or the administration of tyrosine kinase inhibitors are not possible or contraindicated.
Aleksandra Kukulska, Jolanta Krajewska, Zofia Kołosza, Aleksandra Grządziel, Mateusz Gajek, Ewa Paliczka-Cieślik, Dorota Syguła, Kornelia Ficek, Aneta Kluczewska-Gałka, Barbara Jarząb   +9 more
doaj   +1 more source

Stereotactic Radiotherapy for Trigeminal Schwannomas [PDF]

Neurosurgery, 2012
Data on radiotherapy for trigeminal schwannomas (TSs) and comparison of stereotactic radiosurgery (SRS) with fractionated stereotactic radiotherapy (FSRT) are limited.We present a large retrospective review of our institutional experience treating TSs with SRS and FSRT.
Colin E, Champ, Mark V, Mishra, Wenyin, Shi, Joshua, Siglin, Maria, Werner-Wasik, David W, Andrews, James J, Evans   +6 more
openaire   +2 more sources